PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |diabetes |
| Sentences | 529 |
| PubMedID- 24082791 | The relative risk of cardiovascular disease for persons with diabetes is double or more than that of persons without diabetes,14 although the absolute risk of cardiovascular disease varies around the world. |
| PubMedID- 23028919 | Abdominal obesity; waist circumference≥90 in both genders, tlgs; tehran lipid and glucose study, egfr; estimated glomerular filtration rate,igt; impaired glucose test, ifg; impaired fast glucose, dm, diabetes, hcvd, history of cardiovascular disease, fhdm; family history of diabetes mellitus, bmi; body mass index. |
| PubMedID- 24465187 | The hrs were adjusted for cohort as a random effect and for sex, age, body mass index, smoking, total cholesterol, diabetes mellitus, and history of cardiovascular disease as fixed effects. |
| PubMedID- 25922835 | Resistin has been recognised as an adipocytokine positively correlated with insulin resistance and type 2 diabetes and is predictive of cardiovascular disease [15, 16]. |
| PubMedID- 26102958 | Objective: obesity and diabetes enhance the risk of developing cardiovascular diseases and heart failure. |
| PubMedID- 25251664 | Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. |
| PubMedID- 22258465 | diabetes is associated with high cardiovascular disease (cvd) morbidity, especially in patients with ckd. |
| PubMedID- 22430605 | In view of the high incidence of macrovascular diseases in patients with type 2 diabetes mellitus and microalbuminuria, the study evaluates the association of microalbuminuria with fasting plasma apo b48 levels, a marker of the residual presence of intestinally derived trls lipoproteins, thought to be highly atherogenic. |
| PubMedID- 24690919 | Risk factors for cardiovascular disease including diabetes have seen a large rise in prevalence in recent years. |
| PubMedID- 26038692 | Although diabetes mellitus is associated with increased vascular disease, it has not been described as a cause of severe pituitary hypofunction because of the protection provided by the many vessels that feed the circle of willis. |
| PubMedID- 24462067 | Results of epidemiologic studies that investigated the significance of pulse pressure (pp) and mean arterial pressure (map) in terms of risk of cardiovascular disease (cvd) in patients with diabetes mellitus are inconsistent. |
| PubMedID- 20843975 | Improvements in metabolic control have already been shown to have decreased the frequency of serious complications such as proliferative retinopathy, nephropathy, and cardiovascular disease seen in patients with type 1 diabetes (15,16). |
| PubMedID- 22162800 | Peripheral microvascular complications in diabetes are associated with concurrent cerebrovascular disease. |
| PubMedID- 23140093 | Micro- and macrovascular disease associated with diabetes and/or treatment for diabetes may also put these patients at a higher risk of fracture-healing complications; for example, thiazolidinidiones have been shown to be associated with an increased risk of fracture (dormuth et al. |
| PubMedID- 26558824 | Questionnaires about hypertension, diabetes, hypercholesterolemia, family history of early-onset cardiovascular disease, smoking, alcohol consumption, and sedentary lifestyle were administered. |
| PubMedID- 24059905 | The risk factors for ischemic stroke include aging, hypertension, diabetes, smoking, history of cardiovascular diseases, atrial fibrillation, and left ventricular hypertrophy [8,9]. |
| PubMedID- 22682738 | Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. |
| PubMedID- 24779961 | Moreover, circulating levels of tnfr2 predict morbidities such as cardiovascular disease and nephropathy in patients with type 2 diabetes (14,15). |
| PubMedID- 19232762 | Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials. |
| PubMedID- 24172142 | Furthermore, there was a strong increase in the proportion of patients between 40 and 70 years suffering from cardiovascular diseases in combination with hyperlipidemia and/or diabetes mellitus. |
| PubMedID- 26339200 | Capillary blood glucose was considered elevated at ≥5.5 mmol/l, chosen as this is commonly accepted as the threshold for pre-diabetes and increasing risk of vascular disease has been indicated above this value [28]; serum cholesterol levels considered to pose risk for cardiovascular disease were those above the recommended threshold of 5.5 mmol/l [29]. |
| PubMedID- 24616659 | The consequences of poor glucose homeostasis are well-known: hyperglycemia associated with uncontrolled diabetes can lead to cardiovascular disease, neuropathy and nephropathy, while hypoglycemia can lead to convulsions, loss of consciousness, coma, and even death. |
| PubMedID- 20357382 | Management of diabetes in patients with cardiovascular disease is complicated by the fact that the cardiovascular safety of some oral glucose–lowering agents has been questioned, and outcome data are lacking (8). |
| PubMedID- 23410093 | We were also able to characterize several biological determinants in the association between depression and cardiovascular disease in individuals with diabetes, including measures of hpa axis activity (i.e. |
| PubMedID- 20978091 | Insulin resistance predicts the extent of coronary artery calcification and may contribute to the increased risk of cardiovascular disease in patients with type 1 diabetes as well as subjects without diabetes. |
| PubMedID- 21871097 | Background: the presence of microalbuminuria can be associated with overt nephropathy and cardiovascular disease in patients with type 1 diabetes (t1d). |
| PubMedID- 24505486 | Further confining the analysis to participants with complete data for bmi, waist circumference, blood pressure, smoking status, diabetes status, history of cardiovascular disease, poverty:income ratio and time of day of venepuncture gave a total of n = 19,381 included in the analyses of serum phosphorus, total alp and estimated dietary phosphorus intake. |
| PubMedID- 23670279 | Exclusion criteria were a history of respiratory or cardiovascular disease, including diabetes, hypertension, and hypercholesterolemia; symptoms suggesting osa; and taking medication for any of the above-mentioned conditions currently or in the past. |
| PubMedID- 23723672 | One of the early markers of not only diabetic nephropathy, but also vascular disease in patients with diabetes, is the presence of microalbuminuria. |
| PubMedID- 24651718 | Glp-1 receptor agonist represents a novel approach for the treatment of patients with cardiovascular disease associated with type 2 diabetes [28]. |
| PubMedID- 22933440 | (30), who found diabetes-related markers of cerebrovascular disease to be more pronounced among individuals in later stages of cognitive decline (i.e., with dementia). |
| PubMedID- 23264288 | After full-text review of 33 articles, 15 studies were excluded because they were missing sufficient data, did not report rr or hr estimates, and assessed cardiovascular disease with type 2 diabetes or genetic variants of crp. |
| PubMedID- 23185202 | Cardiovascular disease is common in patients with diabetes mellitus and related clinical outcomes are worse compared with non-diabetics. |
| PubMedID- 26186882 | Erratum to: favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the fenofibrate intervention and event lowering in diabetes (field) study. |
| PubMedID- 26341126 | For example, these challenges stem from people with diabetes most frequently dying of cardiovascular diseases or renal failure, and the physicians who record and determine the causes of death may miss and underestimate the contributions of diabetes on death [11–19, 32]. |
| PubMedID- 22851545 | Background: endothelial damage and dysfunction are crucial mediators that link diabetes mellitus with atherosclerotic cardiovascular disease. |
| PubMedID- 20507274 | Since statins are drugs commonly prescribed for the prevention of cardiovascular disease even in patients with prediabetes or diabetes, it is of great importance to identify the role of statin treatment on glucose homeostasis. |
| PubMedID- 23748249 | Among japanese who consume rice as a major staple food, dietary strategies that prevent type 2 diabetes without increasing risk of cardiovascular disease might need to be explored. |
| PubMedID- 25197673 | Objective: to investigate the potential benefits of acarbose treatment on cardiovascular disease (cvd) in patients with type 2 diabetes by using nationwide insurance claim dataset. |
| PubMedID- 23810406 | Conclusion: achieving adequate control of risk factors for cardiovascular disease in patients with type 2 diabetes remains a clinical challenge. |
| PubMedID- 22530043 | Furthermore, in that study, lvm regression was independently associated with improved patient survival even after adjustment for age, gender, diabetes, history of cardiovascular disease, and all nonspecific cardiovascular risk factors. |
| PubMedID- 23718574 | Cardiovascular diseases in patients with type 2 diabetes are a large and increasing health problem. |
| PubMedID- 26171855 | Standardized questionnaires were performed in all patients to collect information regarding age, gender, underlying systemic diseases such as diabetes, hypertension, history of cerebrovascular diseases, and hyperlipidemia, dietary habit, smoking history and body mass index (bmi). |
| PubMedID- 24278703 | Finally, the results of the accord trial showed that the combination of fenofibrate and simvastatin does not reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus, as compared with statin monotherapy [78]; only subgroups of patients with dyslipidemia seem to benefit from fibrate therapy. |
| PubMedID- 20877687 | Endothelial dysfunction is a major contributor to the pathogenesis of vascular disease in diabetes mellitus patients and has recently received increased attention. |
| PubMedID- 25815676 | Glucagon-like peptide-1 (glp-1) has been demonstrated to play an important role in type 2 diabetes mellitus, leading to cardiovascular diseases. |
| PubMedID- 20671994 | Their efficacy in patients with type 2 diabetes in the absence of cardiovascular disease has not been established through clinical trials, although they are widely recommended. |
| PubMedID- 21256163 | Cardiovascular disease is common in patients with diabetes and is a significant contributor to the high mortality rates associated with diabetes. |
| PubMedID- 23536133 | Biomarker samples were collected as part of the markers and mechanisms of vascular disease in diabetes sub-study. |
| PubMedID- 19859073 | The burden of microvascular disease in patients with type 2 diabetes mellitus continues to escalate worldwide. |